Joshua Tarnoff

King Of Prussia, Pennsylvania, United States
Before joining Nephcure in 2018, Mr. Tarnoff joined Complexa in 2011 as Director, President and Chief Executive Officer bringing nearly 30 years of pharmaceutical experience. He has built and led businesses within large pharma and biotechnology companies as well as multiple early stage start-ups. His most recent roles include CEO of JDP Therapeutics, CEO of Houston Pharma (and its subsidiary Potomac Pharma), and CCO at ViroPharma. One of his many roles within large pharma was leading a $1.5 billion U.S. business unit at AstraZeneca. He is a recognized industry figure for his leadership in creating successful management teams, building start-up companies, strategic planning and corporate development.

Mr. Tarnoff also has a strong record of a series of capital raises. With a career that advanced within the executive ranks of the commercial and operations side of the industry, he brings a unique set of skills that blend clinical and business development that lead to successful exits. Mr. Tarnoff received a bachelor’s degree in Biology from LaSalle University.
Speaking In
[Available On-Demand]
There is nothing scarier than going through a health crisis alone, that’s why NephCure’s Patient…